IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Novozymes Breaks Ground in China for Hyaluronic Acid Unit

12:03 AM MDT | May 11, 2009 | DEEPTI RAMESH

Novozymes says it has broken ground on a facility to produce bacillus-based hyaluronic acid (bHA) at its existing Tianjin, China site. The company is also considering establishing a cluster of facilities at the site to produce bulk active pharmaceutical ingredients, which would facilitate expansion as business opportunities develop, Novozymes says. Novozymes expects to invest $35 million–$50 million to build the plant, which is set to be completed in first-quarter 2011. ...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa